Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
International Journal of Oncology
|
July 5, 2011
Protein-based nanotechnology: antibody conjugated with photosensitizer in targeted anticancer photoimmunotherapy
Jerzy Jankun
Experimental and Therapeutic Medicine
|
November 22, 2012
Challenging delivery of VLHL NS plasminogen activator inhibitor-1 by osmotic pumps in diabetic mouse: A case report
Jerzy Jankun
Polskie Archiwum Medycyny Wewnetrznej
|
August 22, 2009
Yin and yang of the plasminogen activator inhibitor
Jerzy Jankun, Ewa Skrzypczak-Jankun
International Journal of Molecular Medicine
|
June 2, 2010
Theaflavin digallate inactivates plasminogen activator inhibitor: could tea help in Alzheimer's disease and obesity?
Ewa Skrzypczak-Jankun, Jerzy Jankun
Experimental and Therapeutic Medicine
|
September 21, 2012
Bleeding diathesis is associated with an A15T heterozygous mutation in exon 2 of the plasminogen activator inhibitor type 1
Jerzy Jankun, Ewa Skrzypczak-Jankun
International Journal of Oncology
|
May 26, 2015
Plasminogen activation system in oral cancer: Relevance in prognosis and therapy (Review)
Marzena Wyganowska-Świątkowska, Jerzy Jankun
Cardiovascular & Hematological Disorders Drug Targets
|
August 31, 2013
Plasminogen activator inhibitor with very long half-life (VLHL PAI-1) can reduce bleeding in PAI-1-deficient patients
Jerzy Jankun, Ewa Skrzypczak-Jankun
Biomed Research International
|
April 18, 2015
Application of long-acting VLHL PAI-1 during sutureless partial nephrectomy in mice reduces bleeding
Khaled Shahrour, Rick Keck, Jerzy Jankun
Computer Aided Surgery : Official Journal of the International Society for Computer Aided Surgery
|
March 16, 2004
Computer simulation of prostate cryoablation--fast and accurate approximation of the exact solution
Adam Wojtowicz, Steve Selman, Jerzy Jankun
International Journal of Molecular Medicine
|
March 26, 2013
Analysis of the inhibition of PAI-1 by metal theaflavin complexes and their degradation products
Jerzy Jankun, Victor Kondray, Ewa Skrzypczak-Jankun
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
International Journal of Oncology
|
July 5, 2011
Protein-based nanotechnology: antibody conjugated with photosensitizer in targeted anticancer photoimmunotherapy
Jerzy Jankun
Experimental and Therapeutic Medicine
|
November 22, 2012
Challenging delivery of VLHL NS plasminogen activator inhibitor-1 by osmotic pumps in diabetic mouse: A case report
Jerzy Jankun
Polskie Archiwum Medycyny Wewnetrznej
|
August 22, 2009
Yin and yang of the plasminogen activator inhibitor
Jerzy Jankun, Ewa Skrzypczak-Jankun
International Journal of Molecular Medicine
|
June 2, 2010
Theaflavin digallate inactivates plasminogen activator inhibitor: could tea help in Alzheimer's disease and obesity?
Ewa Skrzypczak-Jankun, Jerzy Jankun
Experimental and Therapeutic Medicine
|
September 21, 2012
Bleeding diathesis is associated with an A15T heterozygous mutation in exon 2 of the plasminogen activator inhibitor type 1
Jerzy Jankun, Ewa Skrzypczak-Jankun
International Journal of Oncology
|
May 26, 2015
Plasminogen activation system in oral cancer: Relevance in prognosis and therapy (Review)
Marzena Wyganowska-Świątkowska, Jerzy Jankun
Cardiovascular & Hematological Disorders Drug Targets
|
August 31, 2013
Plasminogen activator inhibitor with very long half-life (VLHL PAI-1) can reduce bleeding in PAI-1-deficient patients
Jerzy Jankun, Ewa Skrzypczak-Jankun
Biomed Research International
|
April 18, 2015
Application of long-acting VLHL PAI-1 during sutureless partial nephrectomy in mice reduces bleeding
Khaled Shahrour, Rick Keck, Jerzy Jankun
Computer Aided Surgery : Official Journal of the International Society for Computer Aided Surgery
|
March 16, 2004
Computer simulation of prostate cryoablation--fast and accurate approximation of the exact solution
Adam Wojtowicz, Steve Selman, Jerzy Jankun
International Journal of Molecular Medicine
|
March 26, 2013
Analysis of the inhibition of PAI-1 by metal theaflavin complexes and their degradation products
Jerzy Jankun, Victor Kondray, Ewa Skrzypczak-Jankun
Page
of 7